Mucinex Instasoothe Lozenge
FDA Label NDC 72854-261

15 label sections · Submitted to the FDA by Reckitt Benckiser Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Reckitt Benckiser Llc for the product Mucinex Instasoothe (NDC 72854-261). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient (in each lozenge), purpose, uses, warnings, do not use, otc - when using, stop use and ask a doctor or dentist if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly.

Dist. by: Reckitt Benckiser
Nutley, NJ 07110-6100
Made in India

Active Ingredient (In Each Lozenge)

Hexylresorcinol 2.4 mg

Purpose

Oral pain reliever

Do Not Use

  • in children under 6 years of age

Stop Use And Ask A Doctor Or Dentist If

  • sore mouth symptoms do not improve in 7 days
  • irritation, pain, or redness persists or worsens
  • swelling, rash, or fever develops

* Please review the disclaimer below.